The markedly increased risk of diabetes and cardiovascular disease (CVD) underlines the importance of this metabolic syndrome congress. Discover pioneering research and explore the latest issues from gut hormones in obesity; GLP-1 mimetics and DPP-4 inhibitors in early diabetes and the metabolic syndrome; the role of the GLP-1 axis in prevention, cardiovascular health and cognition; and lessons from bariatric surgery and interventional diabetology.Learn from world leaders, network with fellow specialist, and enjoy the beautiful, historic setting of Vienna.